Cardiac Biotech Solutions, Inc. (CBSC)
0.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Cardiac Biotech Solutions EPS Diluted (Quarterly) : -0.0008 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0008 |
| March 31, 2026 | -0.0006 |
| December 31, 2025 | -0.0035 |
| September 30, 2025 | -0.0002 |
| June 30, 2025 | -0.0012 |
| March 31, 2025 | -0.0025 |
| December 31, 2024 | -0.0043 |
| September 30, 2024 | -0.0022 |
| June 30, 2024 | -0.0017 |
| March 31, 2024 | -0.0022 |
| December 31, 2023 | -0.0035 |
| September 30, 2023 | -0.0037 |
| June 30, 2023 | -0.0025 |
| March 31, 2023 | -0.0062 |
| December 31, 2022 | -0.0115 |
| September 30, 2022 | -0.0039 |
| June 30, 2022 | -0.0041 |
| March 31, 2022 | -0.0131 |
| December 31, 2021 | -0.0474 |
| September 30, 2021 | -0.0048 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.0058 |
| March 31, 2021 | -0.0251 |
| December 31, 2020 | -0.007 |
| September 30, 2020 | -0.0214 |
| June 30, 2020 | -0.0028 |
| March 31, 2020 | -0.0003 |
| December 31, 2019 | 0.00 |
| June 30, 2019 | -0.0003 |
| March 31, 2019 | 0.0031 |
| December 31, 2018 | -0.0004 |
| September 30, 2018 | -0.0019 |
| June 30, 2018 | -0.0018 |
| March 31, 2018 | -0.0068 |
| December 31, 2017 | -0.0088 |
| September 30, 2017 | -0.0018 |
| June 30, 2017 | -0.0022 |
| March 31, 2017 | -0.0019 |
| December 31, 2016 | -0.0009 |
| September 30, 2016 | -0.0025 |
| June 30, 2016 | -0.0008 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vyome Holdings, Inc. | -0.0977 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1372M |
| Revenue (Quarterly) | 0.0402M |
| Total Expenses (Quarterly) | 0.1773M |
| Enterprise Value | 7.343M |
| Profit Margin (Quarterly) | -341.3% |
| Earnings Yield | -12.75% |
| Normalized Earnings Yield | -17.25 |